Literature DB >> 18192901

The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians.

Maria Iordanidou1, Anna Tavridou, Michalis V Vasiliadis, Kostas I Arvanitidis, John Petridis, Dimitrios Christakidis, Vassilios Vargemezis, George Bougioukas, Vangelis G Manolopoulos.   

Abstract

OBJECTIVES: Type 2 diabetes mellitus and obesity constitute serious health problems. Studies reveal that the 5-HT2C receptor contributes substantially to the regulation of a wide variety of behavioral and physiological processes including feeding and glucose homeostasis. Our aim was to determine the possible association of the -759C/T polymorphism of the 5-HT2C receptor gene with type 2 diabetes and obesity in male and female individuals Caucasian origin.
METHODS: The study population consisted of 151 patients diagnosed with type 2 diabetes and 164 nondiabetic patients, all of Greek origin. Genomic DNA was extracted from peripheral blood and analyzed for the -759C/T polymorphism of the 5-HT2C receptor gene using polymerase chain reaction-restriction fragment length polymorphism method.
RESULTS: The frequency of T allele of the -759C/T polymorphism of the 5-HT2C receptor was significantly lower in the diabetic group (12.6%) than in the nondiabetic group (23.3%) (P=0.003). The genetic risk of type 2 diabetes for patients not carrying the T allele was increased compared with nondiabetic patients (odds ratio (OR)=2.34, 95% confidence interval (CI)=1.36-4.02). The reduced frequency of T allele was present both in male [10% in patients with diabetes and 21.6% in patients without diabetes (P=0.041)] and female patients [14.1% in patients with diabetes and 24.3% in patients without diabetes (P=0.030)]. In contrast, the frequency of T allele was similar in obese (16.4%) and nonobese (17.1%) patients.
CONCLUSIONS: Lower frequency of -759T allele of the 5- HT2C receptor gene was associated with type 2 diabetes but not with obesity in male and female Caucasians. Thus, this polymorphism might constitute a prognostic marker for diabetic risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192901     DOI: 10.1097/FPC.0b013e3282f4ae93

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  5 in total

1.  Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor.

Authors:  Hao Wang; Zhenbo Huang; Liansha Huang; Shaona Niu; Xiurong Rao; Jing Xu; Hui Kong; Jianzhong Yang; Chuan Yang; Donghai Wu; Shihua Li; Xiao-Jiang Li; Tonghua Liu; Guoqing Sheng
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

2.  Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus.

Authors:  Weiyue Ding; Li Xu; Lejun Zhang; Zhijie Han; Qinghua Jiang; Zhe Wang; Shuilin Jin
Journal:  BMC Med Genet       Date:  2018-03-07       Impact factor: 2.103

3.  Lorcaserin improves glycemic control via a melanocortin neurocircuit.

Authors:  Luke K Burke; Emmanuel Ogunnowo-Bada; Teodora Georgescu; Claudia Cristiano; Pablo B Martinez de Morentin; Lourdes Valencia Torres; Giuseppe D'Agostino; Christine Riches; Nicholas Heeley; Yue Ruan; Marcelo Rubinstein; Malcolm J Low; Martin G Myers; Justin J Rochford; Mark L Evans; Lora K Heisler
Journal:  Mol Metab       Date:  2017-07-21       Impact factor: 7.422

4.  Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes.

Authors:  Sofia I I Kring; Thomas Werge; Claus Holst; Søren Toubro; Arne Astrup; Torben Hansen; Oluf Pedersen; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

Review 5.  Central 5-HTR2C in the Control of Metabolic Homeostasis.

Authors:  Ting Yao; Jiehui He; Zhicheng Cui; Ruwen Wang; Kaixuan Bao; Yiru Huang; Ru Wang; Tiemin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-21       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.